chr17-44352404-C-T
Variant summary
The NM_002087.4(GRN):c.1477C>T (p.Arg493*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant is predicted to lead to nonsense-mediated mRNA decay (NMD). The variant allele was found at a cumulative frequency of 0.0000144 (AC=21) in the gnomAD database across 1,461,638 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.0000101. In-silico predictor (BayesDel (noAF)) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000322383: Published functional studies demonstrate a damaging effect (Fujita et al., 2018)".
Frequency
Consequence
NM_002087.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- frontotemporal dementia and/or amyotrophic lateral sclerosisInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- neuronal ceroid lipofuscinosisInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- GRN-related frontotemporal lobar degeneration with Tdp43 inclusionsInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- neuronal ceroid lipofuscinosis 11Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Genomics England PanelApp, Orphanet
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Pathogenic. The variant received 17 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PVS1Null variant in LOF gene | Frameshift/stop-gained, NMD predicted, LoF disease mechanism — very strong (PVS1); Stop-gained (exon 12 of 13) at amino acid 493 of 593, predicted to trigger nonsense-mediated mRNA decay. Loss of function is a known disease mechanism for this gene. | ||
| PS3Functional studies show damaging effect | Well-established functional study supports damaging effect (PS3); SCV000322383: Published functional studies demonstrate a damaging effect (Fujita et al., 2018) | ||
| PM2Absent/extremely low in population databases | Rare in gnomAD for AD/XL gene (popmax AF below threshold) — PM2 Supporting; GnomAD popmax AF = 0.0000101 — borderline rare for AD+AR gene (threshold 0.0001) — PM2 supporting. | ||
| PP5Reputable source reports pathogenic | ClinVar 2-star pathogenic — strong (PP5); ClinVar germline classification: Pathogenic/Likely Pathogenic, 2 star(s). |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_002087.4. You can select a different transcript below to see updated classification assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GRN | TSL:1 MANE Select | c.1477C>T | p.Arg493* | stop_gained | Exon 12 of 13 | ENSP00000053867.2 | P28799-1 | ||
| GRN | c.1477C>T | p.Arg493* | stop_gained | Exon 12 of 13 | ENSP00000570986.1 | P28799-1 | |||
| GRN | c.1477C>T | p.Arg493* | stop_gained | Exon 13 of 14 | ENSP00000570988.1 | P28799-1 |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | Cov:33 | ||||
GnomAD2 exomes | AF: 0.00000796 | AC:2 | AN:251110 | ||
GnomAD4 exome | AF: 0.0000144 | AC:21 | Hom:0 | AN:1461638 | Cov:34 |
GnomAD4 genome | Cov:33 | ||||
TOPMed (Bravo) | AF: 0.0000151 | AC:4 | Hom:0 | AN:264690 | |
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.0000913 | AC:7 | Hom:0 | AN:76642 | |
Local & regional cohorts 2 sources | |||||
ESP6500 (Exome Variant Server) | AF: 0.0000769 | AC:1 | AN:13006 | ||
UK10K | AF: 0.000132 | AC:1 | AN:7562 | ||
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
BipEx | 0.0000352 | 1 | 28420 | 0.00 | 0 | 28844 |
Epi25 | 0.00 | 0 | 41958 | 0.0000150 | 1 | 66888 |
SCHEMA | 0.0000314 | 3 | 95474 | 0.00000604 | 1 | 165678 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 34 | |
BayesDel_addAF | Pathogenic | 0.63 | D |
BayesDel_noAF | Pathogenic | 0.29 | |
CADD | Pathogenic | 36 | |
DANN | Uncertain | 0.99 | |
Eigen | Uncertain | 0.28 | |
Eigen_PC | Benign | -0.0022 | |
FATHMM_MKL | Benign | 0.17 | N |
GPN-Star LLR | N/A | -8.9 | |
GPN-Star score | N/A | 8.9 | |
Mutation Taster | N/A | 3/197 | disease causing (ClinVar) |
PhyloP100 | Benign | 0.48 | |
PromoterAI | N/A | 0.023 | Neutral |
RBP_binding_hub_radar | N/A | 0.0 | |
RBP_regulation_power_radar | N/A | 1.9 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.